 | Up a level |
Lang, Alois B; Rüdeberg, Anna; Schöni, Martin H; Que, John U; Fürer, Emil; Schaad, Urs B (2004). Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection. Pediatric infectious disease journal, 23(6), pp. 504-10. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/01.inf.0000129688.50588.ac
Rüdeberg, A (2000). [Cystic fibrosis: current therapy. Fertility versus sterility]. Schweizerische medizinische Wochenschrift - Supplementum, 122, 28S-32S. Basel: EMH Editores Medicorum Helveticorum
Lang, A B; Schaad, U B; Rüdeberg, A; Wedgwood, J; Que, J U; Fürer, E; Cryz, S J (1995). Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Journal of pediatrics, 127(5), pp. 711-7. New York, N.Y.: Elsevier 10.1016/S0022-3476(95)70158-3
Cryz, Stanley J.; Wedgwood, Joanna; Lang, Alois B.; Ruedeberg, Anna; Que, J. U.; Fürer, Emil; Schaad, Urs B. (1994). Immunization of Noncolonized Cystic Fibrosis Patients against Pseudomonas aeruginosa. Journal of infectious diseases, 169(5), pp. 1159-1162. The University of Chicago Press 10.1093/infdis/169.5.1159
Kaiser, G L; Rüdeberg, A (1993). Congenital cerebrospinal fluid mass lesions: does it make sense? European journal of pediatric surgery, 3 Suppl 1, pp. 28-29. Stuttgart: Thieme
Liechti-Gallati, S; Parsai, I; Kraemer, R; Rudeberg, A; Braga, S; Moser, H (1991). The delta F508-deletion in 99 CF patients of Switzerland. Advances in experimental medicine and biology, 290, pp. 367-368. Wien: Springer
Slongo, T; Kehrer, B; Braga, S; Rüdeberg, A (1989). [Experiences with the early treatment of osteogenesis imperfecta]. Zeitschrift für Kinderchirurgie, 44(5), pp. 293-6. Stuttgart: Hippokrates
